Hepatitis B Titer (Anti-HBs): What It Shows, the 10 mIU/mL Threshold, and What to Do If You're Below It

Hepatitis B serology uses three main markers, and the titer is one of them. Hepatitis B surface antibody (anti-HBs) is the antibody that neutralizes the virus. It appears after a completed vaccine series or after the body clears a natural infection, and its presence above a threshold is the laboratory definition of immunity. That is the "hep B titer."

The other two markers answer different questions. Hepatitis B surface antigen (HBsAg) is a piece of the virus itself; if it is present, the virus is present — a current infection, acute or chronic. Hepatitis B core antibody (anti-HBc) appears only after a natural infection, never from the vaccine, so it separates "immune because vaccinated" from "immune because infected and recovered."

Most forms that ask for a "hep B titer" want only the first column: a quantitative anti-HBs. Our Hepatitis B Immunity Test is that test, reported as a number in mIU/mL with the lab's interpretation. If the question is whether you currently have hepatitis B — after an exposure, or because a screening flagged it — that is the HBsAg test with confirmation, a different order.

Clinical trials of the hepatitis B vaccine showed that people whose anti-HBs reached 10 mIU/mL or more after the series were protected against infection, so ≥10 mIU/mL became the definition of a protective response in CDC and ACIP recommendations. It is a yes/no threshold, not a scale of how protected you are: 12 mIU/mL and 800 mIU/mL both read "immune." Labs print the number alongside their reference interpretation, and institutions go by that interpretation.

Who actually needs the number checked? CDC recommends post-vaccination testing for people whose protection matters most or whose response is least predictable — health care and public-safety personnel with blood exposure risk, dialysis patients, people with HIV or other immunocompromise, infants of mothers with hepatitis B, and sex partners of people with chronic hepatitis B. Nursing and medical programs, hospital occupational-health offices and many universities extend that to everyone they enroll or hire, which is why the titer shows up on nearly every clinical-compliance checklist.

After a vaccine series, wait one to two months after the final dose. Anti-HBs takes several weeks to climb; a titer drawn a week after dose three can read low in someone who is about to be fully protected, and that false low costs a needless booster. Occupational-health offices schedule the draw at the one-to-two-month mark for exactly this reason.

Years after the series, the number is allowed to fall. Antibody levels decline over time, and 15 to 50 percent of people vaccinated as children or adolescents will test below 10 mIU/mL a decade or more later. CDC's position is that a person who responded to the series remains protected through immune memory even when the measured level has waned, and does not need routine boosters. Institutions, however, go by the number on your report — so a low titer years after a documented series is common, expected, and handled with a single booster and retest rather than a new series.

Timing with other requirements: the titer is a simple antibody measurement — no fasting, no preparation, drawn from the same tube as MMR and varicella titers and the TB blood test. If a program wants all of them, one draw covers it.

10 mIU/mL or higher: immune. Upload the full report (the value, the reference interpretation and the lab's name), and you are done with hepatitis B — most programs accept a positive titer of any age.

Below 10 mIU/mL after a documented, completed series: this is the situation the CDC guidance for health care personnel was written for, and the sequence is:

1. One additional vaccine dose, then a repeat titer one to two months later. Most people who responded originally will be back above 10 after a single booster — the dose recalls the immune memory.
2. If the repeat is still below 10, complete a second full series (two more doses) and retest one to two months after the last dose.
3. Still below 10 after two complete series (six doses in total): you are considered a non-responder. CDC guidance is to test for HBsAg and anti-HBc to check whether a past or current infection explains the missing antibody response, and to counsel on exposure precautions; a non-responder who is exposed to hepatitis B needs hepatitis B immune globulin rather than a vaccine. Your program's occupational-health office manages this — it is not a bar to enrollment or employment in itself.

Below 10 with no vaccination record at all: you are treated as unvaccinated and start a series — three doses over six months with the standard vaccines (Engerix-B, Recombivax HB) or two doses one month apart with Heplisav-B, which is licensed for adults 18 and over and is the fastest route to a documented series. The titer is drawn one to two months after the final dose.

One caution on interpretation: an anti-HBs result alone cannot tell you whether the antibody came from the vaccine or from a past infection, and it says nothing about a current infection. If you have never been tested for hepatitis B itself and have a risk factor — a household contact with hepatitis B, birth in a country where it is common, injection drug use, or an occupational exposure — the HBsAg test is the one that answers that question.

For hepatitis B specifically, the titer is usually the better first move — the opposite of the MMR calculation. The quantitative anti-HBs test is $31.99; revaccination is a multi-dose series over one to six months, so a titer that comes back immune saves both the injections and the calendar. The exceptions run the other way: if you have no record of ever being vaccinated and the program accepts a vaccination record, going straight to the series avoids a titer that will almost certainly read non-immune; and if the program requires the titer after the series regardless (most clinical programs do), plan on both.

If the same form also asks for MMR and varicella titers and a TB test — the standard clinical-compliance set — the Pre-Enrollment Health Panel puts all four in one draw. The titer test guide covers the other two titers, and the nursing-student checklist walks through the whole list with the timing math.